相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial
S. Sherf-Dagan et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Cecilia J. Hillard
NEUROPSYCHOPHARMACOLOGY (2018)
The therapeutic potential of targeting the peripheral endocannabinoid/CB1 receptor system
Joseph Tam et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Serum Levels of Endocannabinoids are Independently Associated with Nonalcoholic Fatty Liver Disease
Shira Zelber-Sagi et al.
OBESITY (2017)
Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD
Shiran Udi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Global Health Effects of Overweight and Obesity
Edward W. Gregg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mechanisms, Pathophysiology, and Management of Obesity
Steven B. Heymsfield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014
L. Angrisani et al.
OBESITY SURGERY (2017)
Bariatric endoscopy: state-of-the-art
Vivek Kumbhari et al.
CURRENT OPINION IN GASTROENTEROLOGY (2017)
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways
Fabrizio Montecucco et al.
THROMBOSIS AND HAEMOSTASIS (2015)
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease
Wilfrid Mazier et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study
Joseph Abdulnour et al.
OBESITY (2014)
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Cristoforo Silvestri et al.
CELL METABOLISM (2013)
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines
Alessandra Quercioli et al.
EUROPEAN HEART JOURNAL (2013)
Nutrition Care for Patients with Weight Regain after Bariatric Surgery
Carlene Johnson Stoklossa et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Cut off values for abdominal obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz population (Central Asian region)
Aibek E. Mirrakhimov et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
Thierry Poynard et al.
PLOS ONE (2012)
Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity
Isabelle Matias et al.
PLOS ONE (2012)
CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance
Carmelo Quarta et al.
CELL METABOLISM (2010)
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
Tony Jourdan et al.
DIABETES (2010)
Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease
Jukka Westerbacka et al.
GASTROENTEROLOGY (2010)
Biomarkers of Endocannabinoid System Activation in Severe Obesity
Jack C. Sipe et al.
PLOS ONE (2010)
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
V. Di Marzo et al.
DIABETOLOGIA (2009)
Sustained weight loss after roux-en-y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function
Ana Guijarro et al.
ANNALS OF SURGERY (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men
M. Cote et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
M Bensaid et al.
MOLECULAR PHARMACOLOGY (2003)
分享论文
